ABCC8 p.Glu100Lys
[switch to full view]Comments [show]
None has been submitted yet.
No.
Sentence
Comment
7
Four patients were heterozygous for previously reported mutations and four novel mutations, E100K, G214R, Q485R and N1245D, were identified.
X
ABCC8 p.Glu100Lys 21989597:7:92
status: NEW58 Four mutations are novel (E100K, G214R, Q485R and N1245D) and affect residues conserved across species, and none were present in the dbSNP (November 2010) or 1000 genomes databases (May 2011).
X
ABCC8 p.Glu100Lys 21989597:58:26
status: NEW62 Two of the novel mutations, N1245D and E100K (probands 4 and 7), were inherited from a diabetic parent but grandparental samples were not available to check cosegregation.
X
ABCC8 p.Glu100Lys 21989597:62:39
status: NEWX
ABCC8 p.Glu100Lys 21989597:62:663
status: NEW73 N/M 19 SU 50s Family 1 R1380H/N Family 2 R1380H/N 50s OHA 21 Ins 40s OHA N/M 33 SU N/M 11 SU N/M 18 SU SB Family 3 V222M/G214R V222M/N 45 V222M/G214R 15 Ins Family 4 N1245D/N Family 6 Q485R/N Family 5 V1523L/N Family 7 E100K/N N/M 36 SU N/M 14 Ins N/M 40s OHA 60s Diet N/M 13 SU N/N N/N N/M 42 OHA & Ins N/N 60s Diet N/M 60s Diet ×2 SU Fig. 1 Partial pedigrees showing affected family members, genetic status and treatment (where known).
X
ABCC8 p.Glu100Lys 21989597:73:219
status: NEW82 The evidence for pathogenicity of the E100K and N1245D mutations is less certain, and both probands progressed from gliclazide to insulin therapy.
X
ABCC8 p.Glu100Lys 21989597:82:38
status: NEW63 Four mutations are novel (E100K, G214R, Q485R and N1245D) and affect residues conserved across species, and none were present in the dbSNP (November 2010) or 1000 genomes databases (May 2011).
X
ABCC8 p.Glu100Lys 21989597:63:26
status: NEW67 Two of the novel mutations, N1245D and E100K (probands 4 and 7), were inherited from a diabetic parent but grandparental samples were not available to check cosegregation.
X
ABCC8 p.Glu100Lys 21989597:67:39
status: NEW78 N/M 19 SU 50s Family 1 R1380H/N Family 2 R1380H/N 50s OHA 21 Ins 40s OHA N/M 33 SU N/M 11 SU N/M 18 SU SB Family 3 V222M/G214R V222M/N 45 V222M/G214R 15 Ins Family 4 N1245D/N Family 6 Q485R/N Family 5 V1523L/N Family 7 E100K/N N/M 36 SU N/M 14 Ins N/M 40s OHA 60s Diet N/M 13 SU N/N N/N N/M 42 OHA & Ins N/N 60s Diet N/M 60s Diet &#d7;2 SU Fig. 1 Partial pedigrees showing affected family members, genetic status and treatment (where known).
X
ABCC8 p.Glu100Lys 21989597:78:219
status: NEW87 The evidence for pathogenicity of the E100K and N1245D mutations is less certain, and both probands progressed from gliclazide to insulin therapy.
X
ABCC8 p.Glu100Lys 21989597:87:38
status: NEW